BUZZ-Tekmira Pharmaceuticals Corp: Making more of Ebola drug to take months

Wed Aug 13, 2014 6:29pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Drug developer's shares down 10.8 pct at $16.60 in extended trading

** CEO Mark Murray says exploring possibility of making more of its experimental Ebola treatment

** "Making more of the treatment would take months," Murray said on a conference call

** Tekmira shares jumped about 20 pct on Aug. 7 after U.S. FDA modified clinical hold on company's experimental Ebola drug to enable its potential use in humans infected with the virus